Skip to main content

Table 1 Clinical characteristics of study subjects

From: Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect

  Patients with ASD
(n = 46)
Control subject
(n = 22)
p
Value
Age(years) 26.32 ± 13.28 24.81 ± 9.04 NS
Sex(M/F) 20/26 12/10 NS
ASD (TEE) (mm) 27.42 ± 5.92   
ASD (balloon) (mm) 25.34 ± 7.80   
PAP(mmHg) 36.48 ± 10.30   
RVEDV(ml) 106.54 ± 25.97 69.78 ± 10.46 <0.05
RVESV(ml) 59.73 ± 17.59 33.84 ± 7.18 <0.05
RVEF(%) 44.10 ± 4.72 51.92 ± 5.35 <0.05
ANP(ng/L) 156.42 ± 75.10 82.85 ± 17.80 <0.05
  1. Data are presented mean value ± SD or number (%). ASD = atrial septal defect; TEE = transesophageal echocardiography; RVEDV = right ventricular end-diastolic volume; RVESV = right ventricular end-systolic volume; RVEF = right ventricular ejection fraction; ANP = atrial natriuretic peptide